Related Experiment Video
Updated: May 18, 2026

08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Identification of small molecules that disrupt SSB-protein interactions using a high-throughput screen
1Whitehead Institute for Biomedical Research, Cambridge, MA, USA. bernstei@wi.mit.edu
Methods in Molecular Biology (Clifton, N.J.)
|September 15, 2012
Summary
Researchers developed a high-throughput screen to find small molecules that disrupt essential bacterial protein interactions. This work aids in creating new antibacterial agents by targeting bacterial single-stranded DNA-binding proteins (SSBs).
Area of Science:
- Microbiology
- Biochemistry
- Drug Discovery
Background:
- Bacterial single-stranded DNA-binding proteins (SSBs) are crucial for genome maintenance, interacting with various enzymes.
- Targeting SSB-protein interactions offers a promising strategy for developing novel antibacterial agents.
- Many of these interactions are weak, posing challenges for traditional high-throughput screening methods.
Purpose of the Study:
- To develop a high-throughput screen (HTS) for identifying small molecules that inhibit specific SSB-protein interactions.
- To target the interaction between Exonuclease I (ExoI) and the C-terminal tail of SSB (SSB-Ct).
Main Methods:
- Development of a high-throughput screening assay.
- Focus on the protein-protein interaction between Exonuclease I and the SSB C-terminal tail.
- Utilizing the binding strength between ExoI and SSB-Ct as a key assay parameter.
Main Results:
- Successfully established a high-throughput screen for identifying inhibitors of ExoI-SSB-Ct interaction.
- Demonstrated the feasibility of using this screen to find modulators of essential bacterial protein complexes.
- The screen's effectiveness relies on the inherent binding strength of the ExoI-SSB-Ct interaction.
Conclusions:
- The developed high-throughput screen is a valuable tool for discovering inhibitors of SSB-partner interactions.
- This approach can facilitate the identification of novel antibacterial compounds targeting bacterial genome maintenance pathways.
- Further research can leverage this screen to explore other weak protein-protein interactions relevant to bacterial survival.

